Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12-month randomized clinical trial.

Published in: Acta ophthalmologica (2019)

No difference in need for retreatment was detected between treatment arms of aflibercept and navigated versus conventional laser.

Keyphrases